News
Please use one of the following formats to cite this article in your essay, paper or report: APA. CYTENA GmbH. (2025, January 09). Stable producer cell lines with 99.99% clonality & high recovery.
SAN JOSE, Calif., May 14, 2019 /PRNewswire/ -- Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced an expansion in its partnership with cytena GmbH to launch ...
CYTENA’s B.SIGHT cell dispenser is designed to streamline single-cell isolation in microbiology research. CYTENA, a BICO group company and supplier of high-precision laboratory equipment for handling ...
With the "cytena" device, scientists can isolate cells for the development of cell lines and build microtissues faster and more reproducibly.
CYTENA, a BICO company, proudly announces the launch of C.WASH PLUS, ... the C.WASH PLUS delivers unparalleled consistency and precise dispensing for immune and cell-based assays.
CYTENA’s C.STATION™ and ExcellGene’s CHOExpress® will Reduce Timelines to Generate Clonal Cell Lines . FREIBURG, Germany and MONTHEY, Switzerland, May 03, 2022 / B3C newswire / --Today, CYTENA, a BICO ...
Currently focused on CLD applications, Cytena BPS’s microbioreactors provide precise control over culture conditions, enabling faster and more efficient cell line screening and optimization ...
The patented single-cell printing technology, developed by cytena, enables fully automated isolation of single cells into standard microwell plate formats. The instrument uses an inkjet-like principle ...
Intellia has three candidates from its gene editing and cell therapy platforms headed to a clinic near you in the next year or so. The company previewed its next steps in a first-quarter earnings ...
CYTENA’s C.STATION TM is just such a system, integrating “proven technologies for single-cell cloning, imaging, and advanced cell culture with cutting-edge automation software and a clone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results